Kirurgisk behandling af cancer pancreatis

Magnus Bergenfeldt, Carsten Palnaes Hansen, Michael Bau Mortensen

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


    Surgery remains the only hope for cure in pancreatic cancer. The most common procedures are reviewed. Postoperative morbidity and mortality below 30% and 5%, respectively, are the standard. The benefit of extended lymph node dissection and portal-mesenteric vein resection is dubious. Selected patients with locally advanced cancer may be down-staged with chemo-radiotherapy and eventually resected. Endoscopic stent placement is the preferred method to relieve biliary and/or gastrointestinal obstruction. The outcome is better for patients treated at high-volume centres than at smaller hospitals.

    Bidragets oversatte titelSurgical treatment of pancreatic cancer
    TidsskriftUgeskrift for Laeger
    Udgave nummer18
    Sider (fra-til)1358-60
    Antal sider3
    StatusUdgivet - 2010


    • Humans
    • Palliative Care
    • Pancreas
    • Pancreatectomy
    • Pancreatic Neoplasms
    • Pancreaticoduodenectomy
    • Patient Selection
    • Treatment Outcome

    Fingeraftryk Dyk ned i forskningsemnerne om 'Kirurgisk behandling af cancer pancreatis'. Sammen danner de et unikt fingeraftryk.